Pregnant or lactating women, diabetics, hypoglycemics and people with known medical conditions and/or taking drugs should consult with a licensed physician and/or pharmacist prior to taking dietary supplements
Note carefully what this is and what it is not a range pulled from integrative practice and smaller-trial protocols, not a PCOS-specific therapeutic dose established in a landmark trial
Why the IV-to-subcutaneous gap is not a technicality For many peptides, moving from IV to subcutaneous changes the pharmacokinetics modestly a slower rise, a lower peak, decent bioavailability
In Free Radicals in Biology and Environment (ed Minisci, F.) 3947 (Springer, Dordrecht, 1997)
doi:10.1016/j.envres.2024.118966 Chlebowski RT, Manson JE, Anderson GL, et al